Standards & Guidance: RWE & HEOR
This Powerpoint offers a comprehensive overview of Real World Evidence (RWE) and its evolving use in the biopharmaceutical industry.
Entries by Medical Affairs
Creating an HEOR Function Within Medical Affairs
MAPS explores Health Economics and Outcomes Research (HEOR): Why a Medical Affairs organization needs an HEOR function and how to build this capability.
Field Medical Stakeholders: Partnering for Today and Tomorrow – Episode 3 Medical Affairs
The third episode of the MAPS podcast series exploring Field Medical collaborations with internal and external stakeholders.
The Role of Data and Analytics in Leading and Managing Field Medical Teams
This episode of the MAPS podcast series, Elevate, explores the differing approaches applied in the pharmaceutical and device industries to understand the impact and approach to acquired and internally generated data, analytics, and insights play in delivering value.
Medical Affairs Plans: From Strategic Planning to Measuring Impact – Episode 4
This MAPS podcast describes how cross-functional teams within Medical Affairs can use strategic plans to inform decision making and assess impact of efforts.
Medical Affairs Plans: From Strategic Planning to Measuring Impact — Episode 3
Listeners will understand how the Medical Affairs strategic planning process can drive decision making throughout the year.
Field Medical Stakeholders: Partnering for Today and Tomorrow – Episode 2 Global Product Strategy
Participants will learn the functions and activities of key internal partners and will identify potential areas for compliant collaboration with these partners.
Patient as Priority: Designing and Refining Internal Medical Affairs Training to Support Patient Outcomes
In partnership with experts from Open Health and Janssen EMEA, this episode of the MAPS podcast series Elevate details how to position patients as priority in designing and refining internal training.
History of Real-World Evidence Prior to the 21st Century Cures Act
Medical Affairs thought leaders discuss the Pre-21st Century Cures Act uses of Real World Evidence (RWE) in regulatory decision-making.